| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4410553fa514ec20fab08e96db05580 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd77333dc66d790567627ca8ab56c04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710cf30684e6a2d18fe6a0326d7cc3a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbedd41072d432766cfd21dddef31195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd3ffa8d6ef360a93b0084286f0b5f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae7da8fe169aee623e876781bd444b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858ae57db61631abe79004233a9bf9a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34521ce21ff909dcf2ac63d273402c8 |
| publicationDate |
2020-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3587439-A2 |
| titleOfInvention |
Improved quantification of vaccine compositions |
| abstract |
The invention provides methods and mass-labeled peptides for use in said methods for quantifying the presence of a one or more viral proteins in a sample of a preparation containing agents which bind to said viral protein, using mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides, in particular wherein said viral proteins are antigens in a vaccine for porcine circovirus. |
| priorityDate |
2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |